Aralez Pharma (ARLZ) Slammed, Halted Ahead of PDUFA Date
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Aralez Pharma (NASDAQ: ARLZ) has resumed trading and is down 14%. Today is the company's PDUFA date for YOSPRALA.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dynavax (DVAX) Announces Significant Subgroup Data from HEPLISAV-B Phase 3
- Dipexium Pharma (DPRX) Resumes Trading Following LUDP Halt
- Ligand Pharma (LGND) Announces Submission of Baxdela NDAs to FDA as ABSSSI Treatment
Create E-mail Alert Related CategoriesFDA, Trader Talk, Trading Halts
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!